Aidah Abu Elsoud Alkaissi
Dean of Nursing College,An-Najah National University, Palestine
Title: Role of intravenous dextrose on reducing postoperative nausea and vomiting in children undergoing tonsillectomy and/or adenoidectomy: A randomized, double-blind, controlled study
Biography
Biography: Aidah Abu Elsoud Alkaissi
Abstract
Aim: To evaluate whether the postoperative IV administration of 5% dextrose water following surgery decreases postoperative symptoms focusing on postoperative nausea and vomiting (PONV) in patients undergoing tonsillectomy and/or adenoidectomy.
Methods: Prospective, randomized double-blind, controlled study. Ninty pediatric patients undergoing adenotonsillectomy were randomly assigned into two groups (n=45 each). Dextrose water (DW) and ringer lactate (RL) groups. The incidence of postoperative symptoms was assessed.
Results: The incidence of nausea at 30 min postoperatively in DW group was significantly lower 3(6.7%) than RL group 26(57.8%), p=-0.000. At one hour, the incidence of nausea in the DW group 7 (15.6%) was significantly lower than RL group 21(46.7%), p=0.001. At overall period the incidence of nausea (0-5 hours) in DW group 22(48.9%) was significantly lower than the RL group 35(77.8%), (P-value 0.004). At 30 minutes postoperatively, M±S.D of VAS-N scale in the DW group (0.27+0.81) is significantly lower than the RL group(1.6+1.57), p=0.000. At one hour, in the DW group (0.31±0.73) is significantly lower than the RL group 1.07+1.25, p= 0.001. At discharge from the hospital, in the DW group (0.04±0.3) is significantly lower than the RL group (0.4+0.91), p=0.015. There is a significant difference in the use of rescue anti-emetic medication throughout the study period between the dextrose group 7 (15.6%) compared to ringer lactate group 17 (37.8%), p= 0.017. Dextrose water reduces significantly the incidence of post-operative symptoms that are headache, drowsiness, fatigue, thirst and hunger compared to the RL group, p<0.05.
Conclusion: The administration of intravenous dextrose postoperatively for patients undergoing adenotonsillectomy reduces significantly the incidence and intensity of nausea, the incidence of headache, drowsiness, fatigue, thirst and hunger.